ClinPlus released its performance for the first three quarters, with a net profit attributable to the parent company of 87.3815 million yuan, an increase of 20.92%
ClinPlus released its third-quarter report for 2025, with operating revenue for the first three quarters amounting to 609 million yuan, a year-on-year increase of 2.59%. The net profit attributable to shareholders of the listed company was 87.3815 million yuan, a year-on-year increase of 20.92%. The net profit after deducting non-recurring gains and losses was 69.6744 million yuan, a year-on-year increase of 11.48%. The basic earnings per share were 1.11 yuan
According to the Zhitong Finance APP, ClinPlus (301257.SZ) released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 609 million yuan, a year-on-year increase of 2.59%. The net profit attributable to shareholders of the listed company was 87.3815 million yuan, a year-on-year increase of 20.92%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 69.6744 million yuan, a year-on-year increase of 11.48%. The basic earnings per share were 1.11 yuan
